Literature DB >> 35422917

REDD1 gene knockout alleviates vascular smooth muscle cell remodeling in pulmonary hypertension.

Xiaoyu Fang1, Min Xie1, Xiansheng Liu1, Yuanzhou He1.   

Abstract

OBJECTIVES: Regulated in development and DNA damage responses 1 (REDD1) is an important transcription factor regulating mitochondria homeostasis, which is the important pathological alteration of pulmonary hypertension (PH). However, it is unclear whether REDD1 regulates the PASMCs mitochondria homeostasis by the similar mechanism in pulmonary arterial remodeling induced by hypoxia.
METHODS: The global REDD1-knockout rats (REDD1-KO) on Sprague-Dawley background were used to generate a chronic hypoxia model of PH. Right ventricular hypertrophy and vascular remodeling were detected after exposure to hypoxia. Additionally, proliferation, apoptosis, migration, mitochondria homeostasis, and autophagy were performed in vivo and in vitro.
RESULTS: The current research found that in human and experimental rats of PH, REDD1 expression is upregulated in the PASMCs. REDD1 gene knockout alleviated hypoxia PH and hemodynamic changes effectively and reversed hypoxic pulmonary vascular remodeling. In addition, REDD1 knockdown reduces the impairment of mitochondrial function caused by hypoxia in HPASMCs via autophagy inhibition, and this process may be regulated through the Parkin gene. Moreover, REDD1 knockdown can effectively inhibit the proliferation and migration of hypoxic PASMCs, and induce their apoptosis in vivo and in vitro.
CONCLUSIONS: Our results suggested that REDD1 might be a potential target for improved pulmonary vascular remodeling in PH. AJTR
Copyright © 2022.

Entities:  

Keywords:  PASMCs; REDD1; pulmonary hypertension; vascular remodeling

Year:  2022        PMID: 35422917      PMCID: PMC8991113     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  20 in total

1.  Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis.

Authors:  Peter Horak; Andrew R Crawford; Douangsone D Vadysirisack; Zachary M Nash; M Phillip DeYoung; Dennis Sgroi; Leif W Ellisen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

2.  The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension.

Authors:  Biswajit Chowdhury; Albert Z Luu; Vincent Z Luu; M Golam Kabir; Yi Pan; Hwee Teoh; Adrian Quan; Sandra Sabongui; Mohammed Al-Omran; Deepak L Bhatt; C David Mazer; Kim A Connelly; Subodh Verma; David A Hess
Journal:  Biochem Biophys Res Commun       Date:  2020-01-21       Impact factor: 3.575

Review 3.  Mitochondria in vascular health and disease.

Authors:  Peter Dromparis; Evangelos D Michelakis
Journal:  Annu Rev Physiol       Date:  2012-11-16       Impact factor: 19.318

Review 4.  Pulmonary hypertension: diagnostic approach and optimal management.

Authors:  Nathan Hambly; Fahad Alawfi; Sanjay Mehta
Journal:  CMAJ       Date:  2016-05-02       Impact factor: 8.262

Review 5.  Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circulation       Date:  2015-05-12       Impact factor: 29.690

6.  MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells.

Authors:  Yanyan Gu; Jonathan L Kaufman; Leon Bernal; Claire Torre; Shannon M Matulis; R Donald Harvey; Jing Chen; Shi-Yong Sun; Lawrence H Boise; Sagar Lonial
Journal:  Blood       Date:  2014-04-08       Impact factor: 22.113

7.  REDD1 is required for RAS-mediated transformation of human ovarian epithelial cells.

Authors:  Bin Chang; Guangzhi Liu; Gong Yang; Imelda Mercado-Uribe; Miao Huang; Jinsong Liu
Journal:  Cell Cycle       Date:  2009-03-20       Impact factor: 4.534

8.  KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension.

Authors:  Xiaochen Li; Yuanzhou He; Yongjian Xu; Xiaomin Huang; Jin Liu; Min Xie; Xiansheng Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-23       Impact factor: 5.464

9.  A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity.

Authors:  Shuxi Qiao; Michael Dennis; Xiufeng Song; Douangsone D Vadysirisack; Devika Salunke; Zachary Nash; Zhifen Yang; Marc Liesa; Jun Yoshioka; Shu-Ichi Matsuzawa; Orian S Shirihai; Richard T Lee; John C Reed; Leif W Ellisen
Journal:  Nat Commun       Date:  2015-04-28       Impact factor: 14.919

Review 10.  Is REDD1 a Metabolic Éminence Grise?

Authors:  Christopher Lipina; Harinder S Hundal
Journal:  Trends Endocrinol Metab       Date:  2016-09-06       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.